亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北康寶泰精細化工公司  

精細化工品,中間體及原料藥

搜索
網站公告
湖北康寶泰精細化工有限公司 原料銷售,歡迎新老客戶咨詢合作!
新聞中心
產品分類
  • 暫無分類
聯系方式
  • 聯系人:向生
  • 電話:027-87738651
  • 郵件:505958055@qq.com
  • 傳真:027-87738651
  • QQ:2593677460
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 供應cas14047-28-0 9-(2-羥基丙基)腺嘌呤
供應cas14047-28-0 9-(2-羥基丙基)腺嘌呤
單價 1650.00 / 公斤對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 320公斤起訂10公斤
品牌 中間體
型號 14047-28-0
規格 優質
過期 長期有效
更新 2014-11-14 16:20
 
詳細信息

R)-9-(2-羥基丙基)腺嘌呤

銷售熱線:027-87738691  嚴先生 
 QQ:2389907367
湖北康寶泰精細化工有限公
英文名稱:R-(+)-9-(2-Hydroxypropyl)adenine
 CAS號  :14047-28-0
 分子式 :C8H11N5O
 分子量 :193.21
產品含量:≥97%
 性 狀  :白色粉末
 熔 點  :192-195 ℃
 沸 點  :45.7℃(1 atm)
比旋光度:[α]20/D=+40°~42° (c=0.5, 0.1M HCl)
 密 度  :1.57 g/cm3 (20℃)
 用 途  :用作泰諾福韋(抗HIV藥)中間體
 包 裝  :25公斤紙板桶

©2025 湖北康寶泰精細化工公司 版權所有   技術支持:化工網   訪問量:11441  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |